Search all medical codes

Encounter for screening for infections with a predominantly sexual mode of transmission

ICD10CM code

Medical Policies and Guidelines for Encounter for screening for infections with a predominantly sexual mode of transmission

Related policies from health plans

Apretude (cabotegravir extended-release injectable suspension) (PG158)
Apretude (cabotegravir extended-release injectable suspension) (PG158)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Preventive Care Services - (A004)
Transvaginal Ultrasound, Non-Obstetrical - (0398)

Similar Codes


ICD10CM codes

Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission
Z22.4 - Carrier of infections with a predominantly sexual mode of transmission
Z20.2 - Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
Z11.4 - Encounter for screening for human immunodeficiency virus [HIV]
A63.8 - Other specified predominantly sexually transmitted diseases
Z11 - Encounter for screening for infectious and parasitic diseases
Z11.8 - Encounter for screening for other infectious and parasitic diseases
Z11.9 - Encounter for screening for infectious and parasitic diseases, unspecified
O98.31 - Other infections with a predominantly sexual mode of transmission complicating pregnancy
O98.3 - Other infections with a predominantly sexual mode of transmission complicating pregnancy, childbirth

HCPCS codes

G9228 - Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for
T1023 - Screening to determine the appropriateness of consideration of an individual for participation in a
D0190 - Screening of a patient
G0445 - High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, indivi
S8301 - Infection control supplies, not otherwise specified
G0101 - Cervical or vaginal cancer screening; pelvic and clinical breast examination
H2029 - Sexual offender treatment service, per diem
G0432 - Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, scree
G9618 - Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial
G0102 - Prostate cancer screening; digital rectal examination

CPT4 codes

4293F - Patient screened for high-risk sexual behavior (HIV)
3511F - Chlamydia and gonorrhea screenings documented as performed (HIV)
87110 - Culture, chlamydia, any source
87510 - Infectious agent detection by nucleic acid (DNA or RNA); Gardnerella vaginalis, direct probe techniq
99170 - Anogenital examination, magnified, in childhood for suspected trauma, including image recording when
87810 - Infectious agent antigen detection by immunoassay with direct optical observation; Chlamydia trachom
87808 - Infectious agent antigen detection by immunoassay with direct optical observation; Trichomonas vagin
00920 - Anesthesia for procedures on male genitalia (including open urethral procedures); not otherwise spec
11004 - Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing soft tissue infection; e
87270 - Infectious agent antigen detection by immunofluorescent technique; Chlamydia trachomatis